Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
WSC 2026
EFFECT OF FACTOR XIA INHIBITOR ASUNDEXIAN ON ISCHEMIC STROKE RECURRENCE ACCORDING TO BASELINE INFARCT PATTERN: MRI SUBSTUDY OF OCEANIC-STROKE TRIAL
Date/Time:
October 22, 2026/8:36 -8:46
Presenting Author:
Raed Joundi
Presentation Session:
Late Breaking Science Abstracts 03-Prevention, Rehabilitation & Recovery
© 2026 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
Copies of the Bayer Pharmaceuticals supported presentations obtained from this platform are for personal use only and may not be reproduced or distributed without permission from the authors.
Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the presentations are shared in the interest of scientific exchange.
For any questions, please contact Medical Information at https://www.medicalinformation.bayer.com/
PP-GEN-ALL-0014-1
